Int. Journal of Clinical Pharmacology and Therapeutics, Volume 56 (2018) - December (585 - 596)

Vitamin D is a potential antidepressant in psychiatric outpatients

Khalid K. Abdul-Razzak1, Safa’a O. Almanasrah2, Bayan A. Obeidat2, Aws G. Khasawneh3
1 Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, 2 Department of Nutrition and Food Technology, Faculty of Agriculture, Jordan University of Science and Technology, and 3 Neuroscience Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Add to Cart  

 

DOI 10.5414/CP203309

Abstract

Background: Anxiety and depression are globally-common disorders. In Jordan, the number of people visiting psychiatric clinics has been increasing over the past few years. Low level of vitamin D is associated with musculoskeletal pain (MSP) and is increasingly linked to the pathology of mental disorders. Objective: To assess the prevalence of vitamin D deficiency among psychiatric outpatients and their response to vitamin D supplementation. Materials and methods: 74 outpatients and gender- and age-matched controls were involved. Outpatients were prediagnosed by a psychiatrist to have mental disorders (anxiety, depression, others). The Hospital Anxiety and Depression Scale (HADS) was used to assess psychological symptoms before and after treatment. Patients with low vitamin D received oral vitamin D supplementation. Results: 83.8% had vitamin D deficiency, and 95.95% experienced MSP compared to 40.6% and 0.0% of the controls, respectively. There was a statistically significant difference in vitamin D level (p = 0.011) and the total number of pain sites (p = 0.032) among psychiatric outpatient subgroups. HADS-anxiety and HADS-depression were significantly and inversely associated with vitamin D level and total daily calcium intake, and positively associated with pain severity. Relative to baseline, all measured outcome parameters significantly improved after vitamin D supplementation plus dairy products in 40 psychiatric outpatients. Conclusion: Vitamin D deficiency and MSP were very common among Jordanian psychiatric outpatients independent of diagnostic categories. Vitamin D supplementation plus increased dairy-product intake had a significant positive impact on physical and mental health status in psychiatric outpatients. Screening for vitamin D deficiency and daily calcium intake could be routine for psychiatric evaluation.


Author Details

Authors

Departments

  • 1 Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology,
  • 2 Department of Nutrition and Food Technology, Faculty of Agriculture, Jordan University of Science and Technology, and
  • 3 Neuroscience Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Address

Khalid K. Abdul-Razzak, PhD
Department of Clinical Pharmacy
Jordan University of Science and Technology
Faculty of Pharmacy
PO Box 3030. Irbid-22110 Jordan

Email: [email protected]

Log in for Subscribers

Citation

Khalid K. Abdul-Razzak, Safa’a O. Almanasrah, Bayan A. Obeidat, and Aws G. Khasawneh. Vitamin D is a potential antidepressant in psychiatric outpatients
. 2018; 56: 585-596. doi: 10.5414/CP203309.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart